Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Non-cash Items (2024 - 2025)

Prelude Therapeutics' Non-cash Items history spans 2 years, with the latest figure at $9.5 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 9432.8% year-over-year to $9.5 million; the TTM value through Dec 2025 reached $9.5 million, up 9432.8%, while the annual FY2025 figure was $9.5 million, 9432.8% up from the prior year.
  • Non-cash Items for Q4 2025 was $9.5 million at Prelude Therapeutics, down from $9.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $9.6 million in Q3 2025 and bottomed at $6000.0 in Q1 2025.